Platform Specialty Products, an acquisitive chemical company part-owned by activist investor William Ackman, agreed to acquire rival Arysta LifeScience for $3.51 billion.
from WSJ.com: US Business http://ift.tt/10drtTw
via IFTTT
from WSJ.com: US Business http://ift.tt/10drtTw
via IFTTT
No comments:
Post a Comment